The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach

tudies of Giemsa staining at different sites of the stomach revealed that 75% of the Giemsa-negative seropositiv BackgroundHelicobacter pylori is unevenly distributed in hypochlorhydric environments. The study aim was to elucidate the risk factors for a negative Giemsa staining finding in seropositive subjects by measuring the secretory ability of the stomach. MethodsSubjects aged over 18years were included consecutively after endoscopic biopsy at gastric lesions with color or structural changes. Blood was sampled for the serum pepsinogen (PG) assay and H.pylori serology test. After excluding the subjects with past H.pylori eradication, the risk factors for a negative Giemsa staining finding in seropositive subjects were analyzed. ResultsAmong 872 included subjects, a discrepancy between the serum anti-H.pylori IgG and Giemsa staining findings was found in 158 (18.1%) subjects, including 145 Giemsa-negative, seropositive subjects. Gastric adenocarcinoma/adenoma (OR=11.090, 95% CI=3.490-35.236) and low serum PG II level (OR=0.931, 95% CI=0.899-0.963) were the independent risk factors for a negative Giemsa staining finding in seropositive subjects. The cutoff value of serum PG II level was 7.45ng/mL (area under curve [AUC]=0.904, 95% CI=0.881-0.927). Follow-up se subjects with adenocarcinoma are positive, whereas none of those with low serum PG II level of <7.45ng/mL revealed positive findings. ConclusionsThe risk of a negative Giemsa staining finding in seropositive subjects is increased in gastric adenocarcinoma/adenoma specimens and in subjects with a diminished gastric secretory ability with low serum PG II level of <7.45ng/mL. A false-negative Giemsa staining finding is common in subjects with adenocarcinoma, and therefore, additional biopsies at different sites should be performed in these subjects.